A Wall Street Journal feature follows one individual’s decision to travel to Mexico in search of treatment for addiction using ibogaine, a psychoactive compound derived from a West African plant. Because the substance remains illegal in the United States, some Americans have sought treatment in countries where clinics offer the therapy under medical supervision.
The article explores the broader interest in ibogaine as researchers study its potential effects on addiction and withdrawal, while also examining the risks, regulatory challenges, and ongoing debate surrounding its use. The story provides a close look at the personal motivations driving some patients to pursue treatment outside the U.S. as scientific research into the compound continues to develop.